ClinicalTrials.gg
CompletedNCT07410819Updated Oct 7, 2026

Investigation of the Effectiveness of Cervicothoracic Exercises in Individuals With Carpal Tunnel Syndrome

An interventional study of Conventional Physiotherapy Group and Cervicothoracal Exercise Group in Carpal Tunnel Syndrome (CTS), sponsored by Medipol University. Completed at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Medipol University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 7, 2026Now CompletedStart date moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 130 studies in Carpal Tunnel Syndrome with a site in Turkey — 36 open to participants now, 41 under way, none of them phase 3. Carpal Tunnel Syndrome · Turkey.

Enrollment
32nd of 82
70 · median 60
Started
2026
with 19 others
No phase
75 of 130
21 open now
Registered
111th of 130
by date

Among the 130 studies in Carpal Tunnel Syndrome with a site in Turkey, this one is the 32nd largest by enrollment of the 82 interventional ones that give a count, is one of 20 that started in 2026, is one of 75 with no phase, and was the 111th registered.

Carpal Tunnel Syndrome

591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Open to participants now

36 of the 130 studies in Carpal Tunnel Syndrome with a site in Turkey are open now. Recruiting first, the newest first:

31 more — sign in →

All 36 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 130 studies in Carpal Tunnel Syndrome with a site in Turkey, or all of them as a file.
02

Study summary

This randomized, parallel-group controlled clinical trial evaluated the effects of adding cervicothoracic exercises to conventional physiotherapy on symptoms, functional status, pain, grip strength, and wrist range of motion in individuals with carpal tunnel syndrome (CTS). Seventy adults diagnosed with CTS were randomly allocated to two groups: conventional physiotherapy (n=35) or cervicothoracic exercises combined with conventional physiotherapy (n=35).

The conventional physiotherapy program included transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, median nerve mobilization, wrist range-of-motion exercises, and strengthening exercises. The intervention group received the same conventional physiotherapy program together with cervicothoracic exercises targeting cervical mobility, cervical muscle control, scapular stabilization, and thoracic mobility. Both groups received treatment five days per week for six weeks.

Outcomes were assessed at baseline, at the end of the six-week intervention, and approximately three months after each participant completed the intervention. In this updated record, the Boston Carpal Tunnel Questionnaire (BCTQ) is designated as the primary outcome measure. Its Symptom Severity Scale and Functional Status Scale are scored and reported separately, with higher scores indicating greater symptom severity and functional limitations. The primary assessment time point is the end of the six-week intervention.

Secondary outcome measures include pain intensity assessed using the Visual Analog Scale (VAS), upper extremity function assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, grip strength measured using a Jamar hand dynamometer, and wrist range of motion measured using a goniometer. All outcome measures were repeated at the three-month follow-up. The final post-intervention assessment was completed on 31 May 2026, and the final follow-up assessment was completed on 1 September 2026.

03

Conditions studied

  • Carpal Tunnel Syndrome (CTS)

Keywords

  • Carpal Tunnel Syndrome
  • Exercise
  • Hand Grip Strength
  • Servicothoracic Exercises
  • Wrist Pain
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age over 18
  • Symptom duration of at least 12 weeks,
  • Information about carpal tunnel syndrome received from a physician,
  • Positive Tinel or Phalen test in carpal compression test,
  • Pain intensity, Visual Analog Scale, at least 40 mm out of 100 mm

Exclusion criteria

Exclusion Criteria:

  • Any sensory or motor deficit in the ulnar or radial nerve
  • History of previous surgery or injection in the wrist
  • Trauma to the neck, shoulder, or upper extremity
  • Pregnancy
  • Concurrent cervical radiculopathy or polyneuropathy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Active comparator
    Arm 1 - Conventional Physiotherapy (Control)

    Participants will receive conventional physiotherapy including transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, median nerve mobilization, wrist range-of-motion exercises, and strengthening exercises, five days per week for six weeks

    Other: Conventional Physiotherapy Group

  • Experimental
    Arm 2 - Cervicothoracic Exercises + Conventional Physiotherapy

    Participants will receive cervicothoracic exercises in addition to conventional physiotherapy. Cervicothoracic exercises will target cervical mobility, scapular stabilization, and thoracic spine mobility. Treatment will be applied five days per week for six weeks.

    Other: Conventional Physiotherapy Group · Other: Cervicothoracal Exercise Group

Interventions

  • OtherConventional Physiotherapy Group

    Participants will receive a conventional physiotherapy program consisting of transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, median nerve mobilization, wrist range-of-motion exercises, and hand strengthening exercises. TENS will be applied using sensory-level stimulation without muscle contraction. Therapeutic ultrasound will be delivered over the carpal tunnel region using standard clinical parameters. Median nerve mobilization and wrist exercises will be performed under physiotherapist supervision. The treatment will be administered five days per week for six weeks.

    Also known as: Physical Therapy, Standard Physiotherapy, Conservative Treatment

  • OtherCervicothoracal Exercise Group

    Participants will receive cervicothoracic exercises in addition to the same conventional physiotherapy program. The cervicothoracic exercise program will include cervical mobility exercises, scapular stabilization, and thoracic spine mobility exercises designed to improve proximal neural mechanics and upper limb function. All interventions will be supervised by a physiotherapist and applied five days per week for six weeks.

    Also known as: Cervical and Thoracic Exercise Training, Cervicothoracic Stabilization Exercises, Spinal Mobility and Scapular Stabilization Exercises

06

What researchers measure

Primary outcomes

  1. Boston Carpal Tunnel Syndrome Questionnaire

    This questionnaire will be used to measure hand and wrist symptom and function scores in carpal tunnel syndrome. The scale consists of two sub-sections: Symptom Severity and Functional Status. The Symptom Severity Scale evaluates symptoms such as pain, numbness, tingling, and nighttime awakenings, while the Functional Status Scale measures difficulties in daily living activities such as writing, grasping, and carrying objects. Each item is scored between 1 (no complaints) and 5 (very severe complaints); higher scores indicate more symptoms and functional limitations.

    Time frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).

Secondary outcomes

  1. Disabilities of the Arm Shoulder and Hand (DASH)

    The questionnaire will be used to assess the upper extremity function of the participants. The questionnaire consists of a 30-item scale, and each item is scored between 1 (no difficulty) and 5 (very great difficulty). The total score is converted into a score between 0 and 100; higher scores indicate more functional limitations and symptoms.

    Time frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).

  2. Jamar Hydraulic Hand Dynamometer (Hand Grip Strength)

    Hand grip strength will be measured using a Jamar hydraulic hand dynamometer. Procedure: The patient will be seated upright, with shoulders in a natural position and adduction, and elbows at 90° flexion, when the measurement will be taken with the Jamar dynamometer. Three repetitions will be performed for the measurement, and the average will be taken.

    Time frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).

  3. Visual Analog Scale

    The Visual Analog Scale will be used to assess pain. The Visual Analog Scale is a measurement tool that allows individuals to subjectively assess the intensity of their pain, defined by endpoints of "0 = no pain" and "10 = unbearable pain" on a 10 cm long horizontal line. Participants are asked to mark the point on this line that corresponds to the intensity of the pain they feel. A higher score indicates more severe pain.

    Time frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).

  4. Goniometer (Wrist Range of Motion)

    Wrist joint range of motion (ROM) will be measured with a goniometer, assessing flexion, extension, ulnar deviation, and radial deviation. The participant will be seated with the forearm pronated and supported on a table. For flexion and extension, the pivot will be placed on the ulnar styloid process, the fixed arm aligned with the ulna, and the movable arm along the 5th metacarpal. For ulnar and radial deviation, the pivot will be positioned proximal to the third metacarpal, the fixed arm aligned with the forearm, and the movable arm parallel to the third metacarpal. The fixed arm will remain stationary, each movement will be measured three times, and the average value will be used for analysis.

    Time frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).

07

Study locations

2 sites
  • Istanbul Medipol University Pendik Hospital
    Istanbul, Pendik 340003,4000, Turkey (Türkiye)
  • Istanbul Medipol University & Istanbul Medipol University Pendik Hospital
    Istanbul, Pendik 34000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in May 2026, 3 months.

Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's 3 months is below that.

Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: start Oct 2025 → Feb 2026 and completion May 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 8, 2026
First posted
Feb 13, 2026
StartActual
Feb 13, 2026was Oct 2025
Primary completionActual
May 31, 2026
CompletionActual
Sep 1, 2026was May 2026
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 7, 2026
Start date
Oct 1, 2025→Feb 13, 2026
Oct 7, 2026
Primary completion
May 15, 2026→May 31, 2026 (actual)
Oct 7, 2026
Study completion
May 15, 2026→Sep 1, 2026 (actual)
Oct 7, 2026
Enrollment
60 (estimated)→70 (actual)
Oct 7, 2026
Primary outcomes
1 removed
What changed in the outcomes
  • RemovedVisual Analog ScaleTime frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).
Oct 7, 2026
Secondary outcomes
1 added
What changed in the outcomes
  • AddedVisual Analog ScaleTime frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Recruiting→Completed
    Start date Oct 1, 2025→Feb 13, 2026
    Primary completion May 15, 2026→May 31, 2026 (now actual)
    Study completion May 15, 2026→Sep 1, 2026 (now actual)
    Enrollment 60 (estimated)→70 (actual)
    Primary outcomes 1 removed
    What changed in the outcomes
    • RemovedVisual Analog ScaleTime frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).
    Secondary outcomes 1 added
    What changed in the outcomes
    • AddedVisual Analog ScaleTime frame: Assessment will be taken initially and after the intervention (for 6 weeks, 5 days a week).
    + 7 other changes: verification date, description, design details, arm descriptions, contact details, site details and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07410819
Lead sponsor
Medipol University
Responsible party
Zehranur Kaya (Physiotherapist, Medipol University) — Principal investigator
First posted
Feb 13, 2026
Start date
Feb 13, 2026
Primary completion
May 31, 2026
Completion
Sep 1, 2026
Last update
Oct 7, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion